Shares in Biohaven moved up about 7% on Friday after the company provided an update with respect to its New Drug Application (NDA) for troriluzole for the treatment of adult patients with ...

Dutch immunology company argenx has announced positive top-line data from the pivotal ADAPT SERON Phase III study of Vyvgart ...

Founded in 2016 and headquartered in San Francisco, Multiply Labs designs robotic manufacturing systems for personalized ...

The US Food and Drug Administration on Friday revealed it has begun daily publication of adverse event data from the FDA ...

The US Food and Drug Administration (FDA) granted approval for a second treatment for metabolic dysfunction-associated ...

Parexel has announced the appointment of Jim Anthony to the expanded role of chief commercial officer (CCO) and president of ...

Moderna today revealed that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax (elasomeran), targeting ...

The pharmaceutical industry and the UK government have failed to reach agreement on requested changes to a medicines payment ...

The range of drugs available in the Russian market may significantly decrease in the short term due to protectionist measures ...

US pharma major AbbVie reported positive top-line results from the second of two pivotal studies of the Phase III UP-AA ...

US healthcare giant Johnson & Johnson has announced that it will increase its presence in North Carolina with a 160,000+ ...

The USA and European Union on Thursday released new details of their trade framework, addressing long-standing disputes and ...